The mother of a child with chronic renal failure asks the nurse why her son is getting an injection of erythropoietin. When responding to the mother, the nurse incorporates understanding of which of the following as the rationale?

Choice A reason: Erythropoietin is a glycoprotein hormone produced primarily by the kidneys. In chronic renal failure, the kidneys lose their ability to produce adequate erythropoietin, leading to anemia due to decreased red blood cell production. Administering erythropoietin stimulates the bone marrow to produce red blood cells, thereby correcting anemia and improving oxygen-carrying capacity. This is a cornerstone of anemia management in pediatric and adult patients with end-stage renal disease.

Choice B reason: Metabolic acidosis in chronic renal failure is typically managed through bicarbonate therapy or dietary adjustments, not erythropoietin. While both conditions may coexist, erythropoietin has no direct role in correcting acid-base imbalances.

Choice C reason: Growth delays in children with chronic renal failure are multifactorial and may involve nutritional deficits, hormonal imbalances, and metabolic disturbances. Erythropoietin does not influence linear growth or stature directly. Growth hormone therapy may be considered in some cases, but erythropoietin is not indicated for this purpose.

Choice D reason: Hypocalcemia in renal failure is managed through calcium supplements, vitamin D analogs, and phosphate binders. Erythropoietin does not regulate calcium metabolism and is not used to treat low calcium levels.

Choice A reason: Reduced liver function is not a common complication of Crohn’s disease. While some liver-related conditions such as primary sclerosing cholangitis may co-occur with inflammatory bowel disease, they are more commonly associated with ulcerative colitis than Crohn’s disease.

Choice B reason: Pancreatitis is not a typical complication of Crohn’s disease. Although Crohn’s can affect any part of the gastrointestinal tract, pancreatic involvement is rare and not a primary concern in disease management.

Choice C reason: Stricture formation is a well-known complication of Crohn’s disease. Chronic inflammation leads to fibrosis and narrowing of the intestinal lumen, which can cause bowel obstruction and require surgical intervention. This reflects the transmural nature of Crohn’s pathology, distinguishing it from ulcerative colitis.

Choice D reason: Gallstones may occur in patients with Crohn’s disease, especially when the terminal ileum is involved, affecting bile salt absorption. However, this is a secondary complication and less common than strictures, which are more directly related to the disease’s inflammatory and fibrotic processes.